AQR Capital Management
RVLP

AQR Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

AQR Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,121
Closed -$53K – 2317
2021
Q1 		$53K Buy
16,121
+95
+0.6% +$391 ﹤0.01% 2172
2020
Q4 		$66K Sell
16,026
-54,175
-77% -$312K ﹤0.01% 2172
2020
Q3 		$380K Sell
70,201
-57,588
-45% -$332K ﹤0.01% 1838
2020
Q2 		$860K Buy
127,789
+17,342
+16% +$84.9K ﹤0.01% 1521
2020
Q1 		$351K Buy
+110,447
New +$588K ﹤0.01% 1709

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management's RVLP Position: Q2 2021 in Review

AQR Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 16,121 shares — an estimated $53K sold.

AQR Capital Management first reported a position in RVLP in Q1 2020 and held it in 5 quarters. The position peaked at $860K in Q2 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • AQR Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • AQR Capital Management sold 16,121 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $53K.
  • AQR Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2020 and held it in 5 quarters.
  • AQR Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $860K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.